# SND1

## Overview
Staphylococcal nuclease and tudor domain containing 1 (SND1) is a gene that encodes a multifunctional protein involved in various cellular processes, including RNA metabolism, transcriptional regulation, and lipid homeostasis. The protein, also referred to as Tudor-SN, is characterized by its structural composition of staphylococcal nuclease-like domains and a Tudor domain, which facilitate its interactions with nucleic acids and proteins (NavarroImaz2020Molecular; GutierrezBeltran2016Tudor). SND1 functions as a transcriptional coactivator and is a component of the RNA-induced silencing complex (RISC), playing a critical role in RNA interference and posttranscriptional regulation (NavarroImaz2020Molecular). The protein is implicated in various cancers, where its dysregulation contributes to tumor progression and poor prognosis, making it a potential target for therapeutic intervention (Zhang2023The; Emdad2014Suppression).

## Structure
The SND1 protein, also known as Tudor-SN, is composed of a tandem of four staphylococcal nuclease-like (SN) domains followed by a C-terminal Tudor-SN (TSN) domain, which includes a Tudor domain and a truncated SN-like domain (SN5) (NavarroImaz2020Molecular). The SN domains are part of the oligonucleotide/oligosaccharide-binding fold (OB-fold) superfamily, characterized by a five-stranded β-barrel flanked by three α-helices, which are involved in nucleic acid binding and processing (GutierrezBeltran2016Tudor). The Tudor domain is known for its role in protein-protein interactions, particularly binding symmetrically dimethylated arginine-containing ligands through an aromatic cage (NavarroImaz2020Molecular; Liu2010Structural).

The SND1 protein's structure allows it to participate in various cellular processes, including RNA splicing, interference, and stability, as well as protein and lipid homeostasis (Ochoa2018Insights). It contains distinct ligand-binding sites, with the N-terminal SN domains mediating interactions with co-activators and transcription factors (NavarroImaz2020Molecular). Posttranslational modifications such as acetylation, ubiquitinylation, sumoylation, and phosphorylation have been predicted, along with cleavage sites for caspase-3 and -7 (NavarroImaz2020Molecular). The protein's ability to interact with nucleic acids, individual proteins, and protein complexes is attributed to its multiple domains (GutierrezBeltran2016Tudor).

## Function
The SND1 protein, encoded by the SND1 gene, is a multifunctional protein involved in various molecular and cellular processes. It plays a significant role in lipid metabolism, particularly in cholesterol and glycerophospholipid metabolism, and is associated with lipid droplets and the endoplasmic reticulum (NavarroImaz2020Molecular). SND1 acts as a transcriptional coactivator, interacting with several transcription factors such as c-Myb, STAT6, STAT5, E2F1, and PPARγ, and directly binds to gene promoters to regulate gene expression (NavarroImaz2020Molecular).

In addition to its transcriptional roles, SND1 is involved in posttranscriptional processes, including RNA stabilization, splicing, and RNA interference. It is a component of the spliceosome and the RNA-induced silencing complex (RISC), where it exhibits ribonuclease activity (NavarroImaz2020Molecular). SND1 also participates in the posttranscriptional processing of pri-miRNAs, influencing cellular processes like the cell cycle (NavarroImaz2020Molecular).

Structurally, SND1 contains staphylococcal nuclease domains and a Tudor domain, which facilitate interactions with nucleic acids and proteins, contributing to its roles in RNA metabolism and transcriptional regulation (Ochoa2018Insights). SND1 is active in various intracellular locations, including the endoplasmic reticulum, nuclei, cytosolic RNA-induced silencing complex, stress granules, and lipid droplets (NavarroImaz2020Molecular).

## Clinical Significance
The SND1 gene is implicated in various cancers, where its altered expression or interactions contribute to disease progression and poor prognosis. In gliomas, SND1 is upregulated, correlating with increased tumor aggressiveness and poor patient survival. Its overexpression promotes glioma cell proliferation, invasion, and chemoresistance, while knockdown of SND1 enhances the effectiveness of chemotherapeutic agents like TMZ (Yu2019The; Emdad2014Suppression). In triple-negative breast cancer (TNBC), SND1 is associated with metastasis by promoting CDH1 gene methylation, leading to increased invasion and migration of cancer cells. High SND1 expression in TNBC correlates with poor patient outcomes (Zhang2023The).

SND1 is also overexpressed in hepatocellular carcinoma (HCC), where it contributes to cancer progression by promoting cell viability, growth, and angiogenesis. It interacts with AEG-1 to enhance miR-221 levels, facilitating angiogenesis and metastasis (JARIWALA2014Role). In colorectal cancer, SND1 expression is higher in tumors and is linked to advanced disease stages. It is involved in m6A RNA methylation, which may influence cancer progression (Meng2019Genetic). These findings highlight SND1 as a potential therapeutic target across multiple cancer types.

## Interactions
SND1 (staphylococcal nuclease and tudor domain containing 1) is known to participate in various protein-protein and protein-nucleic acid interactions that are crucial for its role in cellular processes. SND1 interacts with metadherin (MTDH) in the cytoplasm, a relationship significant for RNAi-mediated gene silencing and cancer progression. This interaction facilitates RNA-induced silencing complex (RISC) activity, contributing to the regulation of gene expression (Wang2012Prognostic). In breast cancer, the interaction between SND1 and MTDH stabilizes SND1, promoting cancer cell survival. Disruption of this interaction using a high-affinity peptide leads to SND1 degradation and cytotoxicity in breast cancer cells (Li2021Disruption).

SND1 also interacts with circ SMARCA5 in cervical cancer, where it is involved in inhibiting tumor metastasis. This interaction affects the regulation of the YWHAB gene, with overexpression of circ SMARCA5 inhibiting SND1's binding to YWHAB, thereby reducing cancer cell proliferation and invasion (Zhang2021Circ). Additionally, SND1 is involved in the activation of nuclear factor κB (NF-κB), which upregulates miR-221, a microRNA that plays a role in promoting angiogenesis in hepatocellular carcinoma (Santhekadur2012Multifunction). These interactions highlight SND1's multifaceted role in cancer biology through its involvement in various signaling pathways and gene regulation mechanisms.


## References


[1. (Liu2010Structural) Ke Liu, Chen Chen, Yahong Guo, Robert Lam, Chuanbing Bian, Chao Xu, Dorothy Y. Zhao, Jing Jin, Farrell MacKenzie, Tony Pawson, and Jinrong Min. Structural basis for recognition of arginine methylated piwi proteins by the extended tudor domain. Proceedings of the National Academy of Sciences, 107(43):18398–18403, October 2010. URL: http://dx.doi.org/10.1073/pnas.1013106107, doi:10.1073/pnas.1013106107. This article has 126 citations.](https://doi.org/10.1073/pnas.1013106107)

[2. (JARIWALA2014Role) NIDHI JARIWALA, DEVARAJA RAJASEKARAN, JYOTI SRIVASTAVA, RACHEL GREDLER, MAAGED A. AKIEL, CHADIA L. ROBERTSON, LUNI EMDAD, PAUL B. FISHER, and DEVANAND SARKAR. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review). International Journal of Oncology, 46(2):465–473, November 2014. URL: http://dx.doi.org/10.3892/ijo.2014.2766, doi:10.3892/ijo.2014.2766. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2014.2766)

[3. (Emdad2014Suppression) Luni Emdad, Aleksandar Janjic, Mohammad A. Alzubi, Bin Hu, Prasanna K. Santhekadur, Mitchell E. Menezes, Xue-Ning Shen, Swadesh K. Das, Devanand Sarkar, and Paul B. Fisher. Suppression of mir-184 in malignant gliomas upregulates snd1 and promotes tumor aggressiveness. Neuro-Oncology, 17(3):419–429, September 2014. URL: http://dx.doi.org/10.1093/neuonc/nou220, doi:10.1093/neuonc/nou220. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/neuonc/nou220)

[4. (NavarroImaz2020Molecular) Hiart Navarro-Imaz, Begoña Ochoa, Itsaso García-Arcos, María José Martínez, Yolanda Chico, Olatz Fresnedo, and Yuri Rueda. Molecular and cellular insights into the role of snd1 in lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1865(5):158589, May 2020. URL: http://dx.doi.org/10.1016/j.bbalip.2019.158589, doi:10.1016/j.bbalip.2019.158589. This article has 12 citations.](https://doi.org/10.1016/j.bbalip.2019.158589)

[5. (Meng2019Genetic) Yixuan Meng, Shuwei Li, Dongying Gu, Kaili Xu, Mulong Du, Lingjun Zhu, Haiyan Chu, Zhengdong Zhang, Yuan Wu, Zan Fu, and Meilin Wang. Genetic variants in m6a modification genes are associated with colorectal cancer risk. Carcinogenesis, October 2019. URL: http://dx.doi.org/10.1093/carcin/bgz165, doi:10.1093/carcin/bgz165. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/carcin/bgz165)

[6. (Wang2012Prognostic) Nan Wang, Xilin Du, Li Zang, Nuan Song, Tao Yang, Rui Dong, Tao Wu, Xianli He, and Jianguo Lu. Prognostic impact of metadherin–snd1 interaction in colon cancer. Molecular Biology Reports, 39(12):10497–10504, October 2012. URL: http://dx.doi.org/10.1007/s11033-012-1933-0, doi:10.1007/s11033-012-1933-0. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-012-1933-0)

[7. (Li2021Disruption) Peng Li, Yunjiao He, Teng Chen, Kit-Ying Choy, Tsun Sing Chow, Iris L.K. Wong, Xinqing Yang, Wenqin Sun, Xiaochun Su, Tak-Hang Chan, and Larry M.C. Chow. Disruption of snd1–mtdh interaction by a high affinity peptide results in snd1 degradation and cytotoxicity to breast cancer cells in vitro and in vivo. Molecular Cancer Therapeutics, 20(1):76–84, January 2021. URL: http://dx.doi.org/10.1158/1535-7163.mct-20-0130, doi:10.1158/1535-7163.mct-20-0130. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1158/1535-7163.mct-20-0130)

[8. (Ochoa2018Insights) Begoña Ochoa, Yolanda Chico, and María José Martínez. Insights into snd1 oncogene promoter regulation. Frontiers in Oncology, December 2018. URL: http://dx.doi.org/10.3389/fonc.2018.00606, doi:10.3389/fonc.2018.00606. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2018.00606)

[9. (Santhekadur2012Multifunction) Prasanna Kumar Santhekadur, Swadesh K. Das, Rachel Gredler, Dong Chen, Jyoti Srivastava, Chadia Robertson, Albert S. Baldwin, Paul B. Fisher, and Devanand Sarkar. Multifunction protein staphylococcal nuclease domain containing 1 (snd1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κb and mir-221. Journal of Biological Chemistry, 287(17):13952–13958, April 2012. URL: http://dx.doi.org/10.1074/jbc.M111.321646, doi:10.1074/jbc.m111.321646. This article has 165 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M111.321646)

[10. (Yu2019The) Lin Yu, Jinling Xu, Jing Liu, Huibian Zhang, Cuiyun Sun, Qian Wang, Cuijuan Shi, Xuexia Zhou, Dan Hua, Wenjun Luo, Xiuwu Bian, and Shizhu Yu. The novel chromatin architectural regulator snd1 promotes glioma proliferation and invasion and predicts the prognosis of patients. Neuro-Oncology, 21(6):742–754, February 2019. URL: http://dx.doi.org/10.1093/neuonc/noz038, doi:10.1093/neuonc/noz038. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/neuonc/noz038)

[11. (Zhang2023The) Huibian Zhang, Min Gao, Wenying Zhao, and Lin Yu. The chromatin architectural regulator snd1 mediates metastasis in triple-negative breast cancer by promoting cdh1 gene methylation. Breast Cancer Research, October 2023. URL: http://dx.doi.org/10.1186/s13058-023-01731-3, doi:10.1186/s13058-023-01731-3. This article has 1 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s13058-023-01731-3)

[12. (Zhang2021Circ) Xia Zhang, Qing Zhang, Ke Zhang, Fang Wang, Xiaogai Qiao, and Jinquan Cui. Circ smarca5 inhibited tumor metastasis by interacting with snd1 and downregulating the ywhab gene in cervical cancer. Cell Transplantation, January 2021. URL: http://dx.doi.org/10.1177/0963689720983786, doi:10.1177/0963689720983786. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/0963689720983786)

[13. (GutierrezBeltran2016Tudor) Emilio Gutierrez-Beltran, Tatiana V Denisenko, Boris Zhivotovsky, and Peter V Bozhkov. Tudor staphylococcal nuclease: biochemistry and functions. Cell Death &amp; Differentiation, 23(11):1739–1748, September 2016. URL: http://dx.doi.org/10.1038/cdd.2016.93, doi:10.1038/cdd.2016.93. This article has 61 citations.](https://doi.org/10.1038/cdd.2016.93)